Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - TETRAPHASE PHARMACEUTICALS INC | d441172ds1a.htm |
| EX-1.1 - EX-1.1 - TETRAPHASE PHARMACEUTICALS INC | d441172dex11.htm |
| EX-3.2 - EX-3.2 - TETRAPHASE PHARMACEUTICALS INC | d441172dex32.htm |
| EX-3.5 - EX-3.5 - TETRAPHASE PHARMACEUTICALS INC | d441172dex35.htm |
| EX-3.3 - EX-3.3 - TETRAPHASE PHARMACEUTICALS INC | d441172dex33.htm |
| EX-4.1 - EX-4.1 - TETRAPHASE PHARMACEUTICALS INC | d441172dex41.htm |
| EX-5.1 - EX-5.1 - TETRAPHASE PHARMACEUTICALS INC | d441172dex51.htm |
| EX-10.8 - EX-10.8 - TETRAPHASE PHARMACEUTICALS INC | d441172dex108.htm |
| EX-10.9 - EX-10.9 - TETRAPHASE PHARMACEUTICALS INC | d441172dex109.htm |
| EX-10.6 - EX-10.6 - TETRAPHASE PHARMACEUTICALS INC | d441172dex106.htm |
| EX-10.26 - EX-10.26 - TETRAPHASE PHARMACEUTICALS INC | d441172dex1026.htm |
| EX-10.10 - EX-10.10 - TETRAPHASE PHARMACEUTICALS INC | d441172dex1010.htm |
| EX-10.27 - EX-10.27 - TETRAPHASE PHARMACEUTICALS INC | d441172dex1027.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 21, 2013, except for the matters discussed in Note 13, as to which the date is February 28, 2013, in the Registration Statement (Form S-1/A) and related Prospectus of Tetraphase Pharmaceuticals, Inc., for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 5, 2013